Literature DB >> 2181127

The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis--a randomized controlled trial.

G Kraag1, B Stokes, J Groh, A Helewa, C Goldsmith.   

Abstract

Fifty-three patients with ankylosing spondylitis (AS) were randomly allocated; 26 experimental patients received physiotherapy and disease education, 27 control patients received neither. The primary treatment outcome was change in spinal mobility measured at 4 months by fingertip-to-floor distance. Experimental patients had more improvement in fingertip-to-floor distance (p2 less than 0.004) and in function (p2 less than 0.001) than control patients. Physiotherapy with disease education is effective in the treatment of patients with AS.

Entities:  

Mesh:

Year:  1990        PMID: 2181127

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  30 in total

1.  Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up.

Authors:  E Kruithof; F Van den Bosch; D Baeten; A Herssens; F De Keyser; H Mielants; E M Veys
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

Review 2.  Conventional treatments for ankylosing spondylitis.

Authors:  M Dougados; B Dijkmans; M Khan; W Maksymowych; Sj van der Linden; J Brandt
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

3.  [Recommendations for the management of ankylosing spodylitis after ASAS/EULAR. Evaluation in the German language area].

Authors:  J Braun; J Zochling; E Märker-Hermann; G Stucki; H Böhm; M Rudwaleit; H Zeidler; J Sieper
Journal:  Z Rheumatol       Date:  2006-12       Impact factor: 1.372

Review 4.  Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.

Authors:  J Zochling; D van der Heijde; M Dougados; J Braun
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

5.  Rehabilitation in rheumatic diseases. What's new.

Authors:  M L Jurisson
Journal:  West J Med       Date:  1991-05

6.  Intra-tester and inter-tester reliability of chest expansion measurement in clients with ankylosing spondylitis and healthy individuals.

Authors:  Jagannath Sharma; Hideaki Senjyu; Linda Williams; Colin White
Journal:  J Jpn Phys Ther Assoc       Date:  2004

7.  Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a double-blind, randomized, placebo-controlled trial.

Authors:  Duygu Şilte Karamanlioğlu; Ilknur Aktas; Feyza Unlu Ozkan; Meryem Kaysin; Nuray Girgin
Journal:  Rheumatol Int       Date:  2016-02-29       Impact factor: 2.631

Review 8.  Current guidelines for the drug treatment of ankylosing spondylitis.

Authors:  E Toussirot; D Wendling
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

9.  Core set of recommendations for patients with ankylosing spondylitis concerning behaviour and environmental adaptations.

Authors:  Ernst Feldtkeller; Gudrun Lind-Albrecht; Martin Rudwaleit
Journal:  Rheumatol Int       Date:  2013-03-29       Impact factor: 2.631

10.  Changes of patient-reported outcomes and protein fingerprint biomarkers after exercise therapy for axial spondyloarthritis.

Authors:  Marketa Husakova; Anne Sofie Siebuhr; Karel Pavelka; Maja Spiritovic; Anne-Christine Bay-Jensen; Andrea Levitova
Journal:  Clin Rheumatol       Date:  2017-08-30       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.